<DOC>
	<DOCNO>NCT02742337</DOCNO>
	<brief_summary>â€¢ Given cost risk associate biologic disease modify anti-rheumatic drug ( bDMARDs ) , selection optimal medication imperative . Current attempt identify genetic factor predict bDMARD response effectiveness rheumatoid arthritis patient inconclusive . Furthermore presence epigenetic signature rheumatoid arthritis patient establish . This protocol first step identify practicality feasibility epigenetic testing aid diagnosis and/or medication selection rheumatoid arthritis patient . Subsequent research epigenetic change may indicative bDMARD response and/or safety . If epigenetic signature ( EGS ) exist business need test thus support .</brief_summary>
	<brief_title>Identification Epigenetic Biomarkers Early Detection Rheumatic Disease</brief_title>
	<detailed_description>Two group patient assess presence unique epigenetic signature . The test group , bonafide diagnosis rheumatoid arthritis ( RA ) control group subject fulfill American College Rheumatology 's classification criterion RA . A buccal cell sample blood draw sequence analyzed subject group presence epigenetic signature .</detailed_description>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Test patient Must fulfill 2010 ACR rheumatoid arthritis classification criterion . Must least moderate disease activity ( CDAI ) recent disease activity score Any history NSAID corticosteroid use acceptable Weight time blood draw must great 110 lb . Must RF+ CCP+ Control patient Female ( age : 18 80 ) Must fulfill 2010 ACR rheumatoid arthritis classification criterion . Weight time blood draw must great 110 lb . Age within 5 year test patient . Male Age 17 less History Disease Modifying AntiRheumatic Drugs ( DMARDs ) , biologic DMARDs . History malignancy , except nonmelanoma skin cancer Previous treatment malignancy chemotherapy agent Patient report history HIV , HepB , HepC , TB</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Epigenetic</keyword>
</DOC>